THE HEPARIN-BINDING PECAM-1 ADHESION MOLECULE IS EXPRESSED BY CD34+ HEMATOPOIETIC PRECURSOR CELLS WITH EARLY MYELOID AND B-LYMPHOID CELL PHENOTYPES

被引：0
|
作者：
WATT, SM
WILLIAMSON, J
GENEVIER, H
FAWCETT, J
SIMMONS, DL
HATZFELD, A
NESBITT, SA
COOMBE, DR
机构：
[1] IMPERIAL CANC RES FUND, MED ONCOL LAB, LONDON WC2A 3PX, ENGLAND
[2] IMPERIAL CANC RES FUND, HAEMOPOIESIS LAB, LONDON WC2A 3PX, ENGLAND
[3] INST CHILD HLTH, CELLULAR IMMUNOL UNIT, LONDON WC1N 1EH, ENGLAND
[4] CNRS, BIOL CELLULAIRE & MOLEC FACTEURS CROISSANCE LAB, F-94800 VILLEJUIF, FRANCE
[5] INST MOLEC MED, IMPERIAL CANC RES FUND CELL ADHES LAB, OXFORD, ENGLAND
[6] UNIV OXFORD, SIR WILLIAM DUNN SCH PATHOL, OXFORD OX1 3RE, ENGLAND
来源：
BLOOD | 1993年 / 82卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2649 / 2663
页数：15
相关论文
共 46 条
  • [31] MURINE PLATELET ENDOTHELIAL-CELL ADHESION MOLECULE (PECAM-1)/CD31 MODULATES-BETA(2) INTEGRINS ON LYMPHOKINE-ACTIVATED KILLER-CELLS
    PIALI, L
    ALBELDA, SM
    BALDWIN, HS
    HAMMEL, P
    GISLER, RH
    IMHOF, BA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (10) : 2464 - 2471
  • [32] Higher Dose of CD34+ cells Promotes Early Reconstitution of Natural Killer Cells and Is Associated with Better Outcomes After Unmanipulated Hematopoietic Stem Cell Transplantation for Myeloid Malignancies
    Zhao, Fei
    Shi, Yuanyuan
    Chen, Xin
    Zhang, Rongli
    Pang, Aiming
    Zhai, Weihua
    Yang, Donglin
    He, Yi
    Feng, Sizhou
    Zhang, Ping
    Jiang, Erlie
    Han, Mingzhe
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (09): : 589.e1 - 589.e10
  • [33] Inhibitory effects of platelet-endothelial cell adhesion molecule-1 (PECAM-1) on interletakin-1β-induced nuclear factor kappa B (nfκb) activation in vascular endothelial cells (CC).
    Handa, O
    Cepinskas, G
    Takagi, T
    Kokura, S
    Naito, Y
    Yoshida, N
    Yoshikawa, T
    GASTROENTEROLOGY, 2005, 128 (04) : A88 - A88
  • [34] The immunophenotype of different immature, myeloid and B-cell lineage committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors
    Matarraz, Sergio
    Lopez, Antonio
    Barcena, Paloma
    Luz Sanchez, Maria
    Maria Sayagues, Jose
    Orfao, Alberto
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 27 - 27
  • [35] THE IMMUNOPHENOTYPE OF DIFFERENT IMMATURE, MYELOID AND B-CELL LINEAGE COMMITTED CD34+ HEMATOPOIETIC CELLS ALLOWS DISCRIMINATION BETWEEN NORMAL/REACTIVE AND MYELODYSPLASTIC SYNDROME PRECURSORS
    Sudon, S. Matarraz
    Lopez, A.
    Barrena, S.
    Fernandez, C.
    Jensen, E.
    Flores, J.
    Barcena, P.
    Rasillo, A.
    Sayagues, J. M.
    Sanchez, M. L.
    Rivas, J. M. Hernandez
    Salvador, C.
    Mosteirin, N. Fernandez
    Perdiguer, L.
    Orfao, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 288 - 289
  • [36] The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors
    S Matarraz
    A López
    S Barrena
    C Fernandez
    E Jensen
    J Flores
    P Bárcena
    A Rasillo
    J M Sayagues
    M L Sánchez
    P Hernandez-Campo
    J M Hernandez Rivas
    C Salvador
    N Fernandez-Mosteirín
    M Giralt
    L Perdiguer
    A Orfao
    Leukemia, 2008, 22 : 1175 - 1183
  • [37] The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors
    Matarraz, S.
    Lopez, A.
    Barrena, S.
    Fernandez, C.
    Jensen, E.
    Flores, J.
    Barcena, P.
    Rasillo, A.
    Sayagues, J. M.
    Sanchez, M. L.
    Hernandez-Campo, P.
    Rivas, J. M. Hernandez
    Salvador, C.
    Fernandez-Mosteirin, N.
    Giralt, M.
    Perdiguer, L.
    Orfao, A.
    LEUKEMIA, 2008, 22 (06) : 1175 - 1183
  • [38] Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells
    Wang, MWJ
    Consoli, U
    Lane, CM
    Durett, A
    Lauppe, MJ
    Champlin, R
    Andreeff, M
    Deisseroth, AB
    CELL GROWTH & DIFFERENTIATION, 1998, 9 (02): : 105 - 112
  • [39] The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1
    Möhle, R
    Bautz, F
    Rafii, S
    Moore, MAS
    Brugger, W
    Kanz, L
    BLOOD, 1998, 91 (12) : 4523 - 4530
  • [40] Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells
    van der Kolk, DM
    de Vries, EGE
    Koning, JA
    van den Berg, E
    Muller, M
    Vellenga, E
    CLINICAL CANCER RESEARCH, 1998, 4 (07) : 1727 - 1736
12345